Cargando…

The effect of metformin usage on survival outcomes for hepatocellular carcinoma patients with type 2 diabetes mellitus after curative therapy

OBJECTIVE: Metformin has attracted more attention from researchers for its newly discovered antitumor effects. A meta-analysis was performed to reveal the efficacy of metformin on overall survival (OS) and recurrence-free survival (RFS) for HCC patients with type 2 diabetes mellitus (T2DM) after cur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Bo, Ma, Jichun, Wang, Jing, Hao, Jinyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792596/ https://www.ncbi.nlm.nih.gov/pubmed/36583006 http://dx.doi.org/10.3389/fendo.2022.1060768

Ejemplares similares

Transarterial chemoembolization combined with metformin improves the prognosis of hepatocellular carcinoma patients with type 2 diabetes
por: Chen, Miao-Ling, et al.
Publicado: (2022)

Effect of Metformin on Testosterone Levels in Male Patients With Type 2 Diabetes Mellitus Treated With Insulin
por: Cai, Tingting, et al.
Publicado: (2021)

Metformin Use and Leukemia Risk in Patients With Type 2 Diabetes Mellitus
por: Tseng, Chin-Hsiao
Publicado: (2020)

Comparison of Clinical Efficacy and Safety of Metformin Sustained-Release Tablet (II) (Dulening) and Metformin Tablet (Glucophage) in Treatment of Type 2 Diabetes Mellitus
por: Guo, Li-xin, et al.
Publicado: (2021)

Metformin therapy in pediatric type 2 diabetes mellitus and its comorbidities: A review
por: Alfaraidi, Haifa, et al.
Publicado: (2023)

Metformin treatment and risk of diabetic peripheral neuropathy in patients with type 2 diabetes mellitus in Beijing, China
por: Yang, Ruotong, et al.
Publicado: (2023)

Survival advantage associated with metformin usage in hepatocellular carcinoma patients with diabetes mellitus receiving radical resection: a propensity score matching analysis
por: Luo, Cui-Song, et al.
Publicado: (2019)

Metformin Use Is Not Associated With B(12) Deficiency or Neuropathy in Patients With Type 2 Diabetes Mellitus in Qatar
por: Elhadd, Tarik, et al.
Publicado: (2018)

Impact of Diabetes Mellitus on the Prognosis of Patients with Hepatocellular Carcinoma after Curative Hepatectomy
por: Wang, Yan-Yan, et al.
Publicado: (2014)

Hepatocellular Carcinoma and Obesity, Type 2 Diabetes Mellitus, Cardiovascular Disease: Causing Factors, Molecular Links, and Treatment Options
por: Zhang, Chunye, et al.
Publicado: (2021)

Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial
por: Wilding, J P H, et al.
Publicado: (2013)

Editorial: Metformin: Beyond Diabetes
por: Bost, Frédéric, et al.
Publicado: (2019)

Association of Preadmission Metformin Use and Prognosis in Patients With Sepsis and Diabetes Mellitus: A Systematic Review and Meta-Analysis
por: Li, Yuanzhe, et al.
Publicado: (2021)

Metformin versus placebo in combination with insulin analogues in patients with type 2 diabetes mellitus—the randomised, blinded Copenhagen Insulin and Metformin Therapy (CIMT) trial
por: Lundby-Christensen, Louise, et al.
Publicado: (2016)

Effect of metformin on neurodegenerative disease among elderly adult US veterans with type 2 diabetes mellitus
por: Shi, Qian, et al.
Publicado: (2019)

Metformin Treatment for Diabetes Mellitus Correlates with Progression and Survival in Colorectal Carcinoma
por: Powell, Marta K., et al.
Publicado: (2019)

Metformin-Induced Vitamin B12 Deficiency in Patients With Type-2 Diabetes Mellitus
por: Tiwari, Aakriti, et al.
Publicado: (2023)

Effect and Safety of Adding Metformin to Insulin Therapy in Treating Adolescents With Type 1 Diabetes Mellitus: An Updated Meta-Analysis of 10 Randomized Controlled Trials
por: Liu, Ying, et al.
Publicado: (2022)

The effect of Chinese herbal formulas combined with metformin on modulating the gut microbiota in the amelioration of type 2 diabetes mellitus: A systematic review and meta-analysis
por: Xu, Yunxi, et al.
Publicado: (2022)

Correlation between long-term use of metformin and incidence of NAFLD among patients with type 2 diabetes mellitus: A real-world cohort study
por: Huang, Kuang-Hua, et al.
Publicado: (2022)

Genetically Predicted Causality of 28 Gut Microbiome Families and Type 2 Diabetes Mellitus Risk
por: Xiang, Kun, et al.
Publicado: (2022)

Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: A systematic review, meta-analysis and meta-regression of randomized controlled trials
por: Nabrdalik, Katarzyna, et al.
Publicado: (2022)

Knowledge, Attitude, and Practices of Complementary and Alternative Medication Usage in Patients of Type II Diabetes Mellitus
por: Raja, Ravi, et al.
Publicado: (2019)

GDF-15 as a Weight Watcher for Diabetic and Non-Diabetic People Treated With Metformin
por: Ouyang, Jing, et al.
Publicado: (2020)

Metformin, an Anti-diabetic Drug to Target Leukemia
por: Biondani, Giulia, et al.
Publicado: (2018)

Prevalence of Vitamin B12 Deficiency in Type 2 Diabetes Mellitus Patients on Metformin Therapy
por: TS, Rathis, et al.
Publicado: (2023)

Anthropometric Measures and Incident Diabetic Nephropathy in Participants With Type 2 Diabetes Mellitus
por: Hukportie, Daniel Nyarko, et al.
Publicado: (2021)

Evaluation of Usage of a Fracture Risk Assessment by FRAX Tool in Adults With Type 2 Diabetes Mellitus
por: Santos Monteiro, Sílvia, et al.
Publicado: (2023)

Effectiveness of sitagliptin compared to sulfonylureas for type 2 diabetes mellitus inadequately controlled on metformin: a systematic review and meta-analysis
por: Sharma, Manuj, et al.
Publicado: (2017)

Prevalence of Vitamin B12 Deficiency in Patients with Type II Diabetes Mellitus on Metformin: A Study from Khyber Pakhtunkhwa
por: Khan, Adnan, et al.
Publicado: (2017)

Gut microbiota is correlated with gastrointestinal adverse events of metformin in patients with type 2 diabetes
por: Huang, Yuxin, et al.
Publicado: (2022)

Association of ANGPTL8 and Resistin With Diabetic Nephropathy in Type 2 Diabetes Mellitus
por: Li, Mengni, et al.
Publicado: (2021)

Rationale and design of a randomised controlled trial testing the effect of personalised diet in individuals with pre-diabetes or type 2 diabetes mellitus treated with metformin
por: Htet, Thaw D, et al.
Publicado: (2020)

Distribution characteristics of oral microbiota and its relationship with intestinal microbiota in patients with type 2 diabetes mellitus
por: Guo, Xiao-jing, et al.
Publicado: (2023)

Evaluating Glycemic Control During Basalin or Lantus Administration in Adults With Controlled Type 2 Diabetes Mellitus Using Continuous Glucose Monitoring
por: Wang, Huiying, et al.
Publicado: (2021)

The psychometric properties of the barriers to insulin treatment questionnaire in Chinese patients with type 2 diabetes mellitus using insulin
por: Ma, Min, et al.
Publicado: (2023)

Treatment pathways in people with type 2 diabetes mellitus: a nationwide cohort study of new users of metformin monotherapy in New Zealand
por: Guo, Joyce, et al.
Publicado: (2021)

Effects of mulberry twig alkaloids(Sangzhi alkaloids) and metformin on blood glucose fluctuations in combination with premixed insulin-treated patients with type 2 diabetes
por: Meng, Ziyu, et al.
Publicado: (2023)

Neck-to-height ratio is positively associated with diabetic kidney disease in Chinese patients with type 2 diabetes mellitus
por: He, Zhi-Ying, et al.
Publicado: (2023)

Association Between Plasma Vitamin D2 and Type 2 Diabetes Mellitus
por: Qi, Jing-Wan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m8ktjf0oq1f35iqqsfre8leckm